Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation

Author:

Du Ruochen12ORCID,Tripathi Shashwat12,Najem Hinda12ORCID,Brat Daniel J.3,Lukas Rimas V.24,Zhang Peng12,Heimberger Amy B.12ORCID

Affiliation:

1. Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

2. Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

3. Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

4. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA

Abstract

Macrophages and microglia are professional phagocytes that sense and migrate toward “eat-me” signals. The role of phagocytic cells is to maintain homeostasis by engulfing senescent or apoptotic cells, debris, and abnormally aggregated macromolecules. Usually, dying cells send out “find-me” signals, facilitating the recruitment of phagocytes. Healthy cells can also promote or inhibit the phagocytosis phenomenon of macrophages and microglia by tuning the balance between “eat-me” and “don’t-eat-me” signals at different stages in their lifespan, while the “don’t-eat-me” signals are often hijacked by tumor cells as a mechanism of immune evasion. Using a combination of bioinformatic analysis and spatial profiling, we delineate the balance of the “don’t-eat-me” CD47/SIRPα and “eat-me” CALR/STC1 ligand–receptor interactions to guide therapeutic strategies that are being developed for glioblastoma sequestered in the central nervous system (CNS).

Funder

NIH

Publisher

MDPI AG

Reference82 articles.

1. Characterization of gliomas: From morphology to molecules;Ferris;Virchows Arch.,2017

2. The 2021 WHO Classification of Tumors of the Central Nervous System: A summary;Louis;Neuro Oncol.,2021

3. Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice;Lukas;Neurooncol. Pract.,2017

4. Combined nivolumab and ipilimumab in melanoma metastatic to the brain;Tawbi;N. Engl. J. Med.,2018

5. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001;Hamid;Ann. Oncol.,2019

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond;Current Issues in Molecular Biology;2024-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3